Final ICH Addendum Offers Latest Perspectives On Pediatric Drug Development
A new document that complements the International Council for Harmonisation's existing guideline on pediatric clinical trials is expected to reduce the likelihood of significant differences among countries on the acceptance of data generated in pediatric global drug development programs